These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24486207)

  • 1. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
    Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
    J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells.
    Jones JC; Turpin EA; Bultmann H; Brandt CR; Schultz-Cherry S
    J Virol; 2006 Dec; 80(24):11960-7. PubMed ID: 17005658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors against influenza virus.
    Rajik M; Yusoff K
    Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.
    Matsubara T; Sumi M; Kubota H; Taki T; Okahata Y; Sato T
    J Med Chem; 2009 Jul; 52(14):4247-56. PubMed ID: 19558186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.
    Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Han SZ; Park MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):14-9. PubMed ID: 24012672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
    Mazur I; Wurzer WJ; Ehrhardt C; Pleschka S; Puthavathana P; Silberzahn T; Wolff T; Planz O; Ludwig S
    Cell Microbiol; 2007 Jul; 9(7):1683-94. PubMed ID: 17324159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
    Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
    J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
    Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
    Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of fluvastatin on influenza virus infection.
    Peng J; Zhang D; Ma Y; Wang G; Guo Z; Lu J
    Mol Med Rep; 2014 Jun; 9(6):2221-6. PubMed ID: 24676773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.
    Habersetzer F; Leboeuf C; Doffoël M; Zeisel MB; Baumert TF
    Expert Opin Investig Drugs; 2013 Jul; 22(7):853-62. PubMed ID: 23634817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.
    Rimmelzwaan GF; Nieuwkoop NJ; de Mutsert G; Boon AC; Kuiken T; Fouchier RA; Osterhaus AD
    Virus Res; 2007 Nov; 129(2):175-81. PubMed ID: 17714820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
    Lee SM; Yen HL
    Antiviral Res; 2012 Dec; 96(3):391-404. PubMed ID: 23022351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel family of peptides with potent activity against influenza A viruses.
    Nicol MQ; Ligertwood Y; Bacon MN; Dutia BM; Nash AA
    J Gen Virol; 2012 May; 93(Pt 5):980-986. PubMed ID: 22258859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.